Financhill
Back

Protagonist Therapeutics Stock Predictions

Biden's Oil War: The Administration Is All-In on Green Energy.

Download Free Report
Sell
48

PTGX
Protagonist Therapeutics

Last Price:
28.90
Seasonality Move:
24.27%

7 Day Trial

ALL ACCESS PASS

$ 7

S&P Global: Private Equity Invests $36 Billion Into What?

Read More

Protagonist Therapeutics Stock Forecast

  • Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 45.3% based on the past 7 years of stock performance.
  • Protagonist Therapeutics has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
  • Is Protagonist Therapeutics Stock Undervalued?
    The current Protagonist Therapeutics [PTGX] share price is $28.48. The Score for PTGX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Protagonist Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 45.3% based on the past 7 years of stock performance.

Protagonist Therapeutics Stock Rating

Sell
48
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics overpriced?

  • Protagonist Therapeutics has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%

Protagonist Therapeutics Stock Price History

Is PTGX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
protagonist-inc.com

52-Week Data

52-Week High:
33.34
52-Week Low:
13.72

Prediction Charts

Market Cap:
1.66B
Price in USD:
28.48
Volume:
359.3K
Beta:
2.08

Technical Analysis

SMA50:
27.81
SMA100:
23.83
SMA200:
21.75
52-Wk Change:
30.88%

Stock Predictions

  • Is Protagonist Therapeutics stock public?
    Yes, Protagonist Therapeutics is a publicly traded company.
  • What is the Protagonist Therapeutics stock quote today?
    The Protagonist Therapeutics stock price is 28.48 USD today.
  • How to buy Protagonist Therapeutics stock online?
    You can buy Protagonist Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-8 31.41 30.32 31.56 30.20
Mar-11 30.32 30.12 30.76 29.78
Mar-12 30.04 29.90 30.57 29.49
Mar-13 29.90 30.20 30.63 29.43
Mar-14 29.88 28.33 29.94 28.14
Mar-15 28.23 28.98 29.97 28.23
Mar-18 28.81 28.45 29.22 28.25
Mar-19 28.56 28.82 28.95 28.26
Mar-20 28.65 28.88 28.94 28.02
Mar-21 29.40 28.35 29.73 28.25
Mar-22 28.37 28.03 28.42 27.83
Mar-25 28.11 27.89 28.44 27.63
Mar-26 28.42 28.00 28.42 27.59
Mar-27 28.17 28.48 28.62 27.94

Protagonist Therapeutics Earnings

Protagonist Therapeutics Earnings Report: Per Share Protagonist Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Protagonist Therapeutics Forecast Revenue Growth

Protagonist Therapeutics Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.23 per share.

* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.